by Scott Miller | Jul 24, 2026
Lead exposure is one of the most widespread and overlooked threats to child health. CHAI and Renaissance Philanthropy have published a consensus Target Product Profile (TPP) that defines what a rapid, low-cost blood lead level test should deliver, to accelerate the...
by Scott Miller | Jul 17, 2026
Updated Sep. 1, 2026: CHAI and its partners have developed an FAQ document to aid stakeholders in understanding the details of the products, the agreement terms, and the potential benefits for TB programs. View the FAQ here. New agreements with DeepTek and Delft...
by Scott Miller | Jul 15, 2026
This is the current list of sessions with CHAI participation at AIDS 2026, which will take place virtually and in-person in Rio de Janeiro, Brazil from July 26 to 31, 2026. Please note that this page is continuously being updated as participants and sessions are...
by Scott Miller | Jul 9, 2026
The Clinton Health Access Initiative, the Agency Fund, and Endless Network have launched the AI Commons for Global Health, a new, shared initiative to ensure that as AI transforms healthcare, it works for the patients who need it most. The initiative emerged from a...
by Scott Miller | Jul 2, 2026
CHAI is pleased to release the 2026 Hepatitis C Treatment Market Memo, the latest in our series of hepatitis C market intelligence publications. A decade ago, curing hepatitis C cost more than US$84,000 per patient. Today, the same cure can be procured at around US$60...
